# Identification of two terpenoids from Withania coagulans with predicted multitarget binding affinity: An in vitro and in silico study

**Authors:** Hansa Gul, Nasir Assad, Zahida Nasreen, Nouman Ahmad, Yasir Assad, Muhammad Nauman Khan, Ahmed Vandy, Michael Lahai, Muhammad Naeem-ul-Hassan, Sezai Ercişli, Yusuf Oloruntoyin Ayipo, Yusuf Oloruntoyin Ayipo, Yusuf Oloruntoyin Ayipo, Yusuf Oloruntoyin Ayipo

PMC · DOI: 10.1371/journal.pone.0343273 · PLOS One · 2026-02-20

## TL;DR

This study identifies two terpenoids in Withania coagulans that show potential as multitarget natural compounds with antibacterial, antidiabetic, and antioxidant properties.

## Contribution

The study reports the discovery of two terpenoids with predicted multi-target binding affinities through in vitro and in silico methods.

## Key findings

- The extract showed antibacterial activity against Salmonella Typhi and Escherichia coli with inhibition zones of 15–25 mm.
- Caryophyllene oxide and 2,2-dimethyl-3-(…)-oxirane were identified as promising multitarget terpenoids with strong predicted binding affinities.
- The extract demonstrated significant antioxidant activity, with radical scavenging increasing from 27.5% to 57.3% as concentration increased.

## Abstract

Withania coagulans (Dunal) Stocks, a medicinal plant of the Solanaceae family, has long been recognized in traditional medicine for its antidiabetic, antimicrobial, and antioxidant activities. In the present study, gas chromatography–mass spectrometry (GC–MS) analysis of the aqueous stem extract of W. coagulans revealed a diverse phytochemical profile, comprising phenolics, terpenoids, and fatty acids. The extract was subsequently assessed for its biological potential using in vitro assays. It exhibited notable antibacterial activity against Salmonella Typhi and Escherichia coli, producing inhibition zones between 15 and 25 mm, comparable to that of standard antibiotics, underscoring its potential as a natural antibacterial agent. The antidiabetic potential of the extract was established by starch hydrolysis and α-amylase inhibition, where the extract achieved 58.33% and 75.8% inhibition, respectively. Antioxidant activity was demonstrated in the DPPH assay, showing a progressive increase in radical scavenging from 27.5% at 100 µg/mL to 57.3% at 500 µg/mL concentration. In silico docking, ADMET analysis, and molecular dynamics simulations identified caryophyllene oxide and 2,2-dimethyl-3-(…)-oxirane as promising lead terpenoids, exhibiting strong predicted binding affinities across antibacterial, antidiabetic, and antioxidant targets. These findings provide scientific support for the ethnopharmacological use of W. coagulans and suggest its potential compounds with predicted multi-target binding affinities.

## Linked entities

- **Chemicals:** caryophyllene oxide (PubChem CID 1742210)
- **Species:** Withania coagulans (taxon 180581), Escherichia coli (taxon 562)

## Full-text entities

- **Genes:** VDAC1 (voltage dependent anion channel 1) [NCBI Gene 7416] {aka PORIN, VDAC-1}, KEAP1 (kelch like ECH associated protein 1) [NCBI Gene 9817] {aka INrf2, KLHL19}, AMY2A (amylase alpha 2A) [NCBI Gene 279] {aka AMY2, PA}
- **Diseases:** asthma (MESH:D001249), Diabetes mellitus (MESH:D003920), cancer (MESH:D009369), Alzheimer (MESH:D000544), insomnia (MESH:D007319), Parkinson diseases (MESH:D010300), pain (MESH:D010146), MD (MESH:D000092242), hyperglycemia (MESH:D006943), neurodegenerative diseases (MESH:D019636), inflammation (MESH:D007249), metabolic dysfunctions (MESH:D008659), ACADEMIC EDITOR (MESH:D007859), microbial infections (MESH:D015163), Toxicity (MESH:D064420), immune-related disorders (MESH:D007154), cardiovascular diseases (MESH:D002318), viral infections (MESH:D014777), diabetic complications (MESH:D048909), rheumatoid arthritis (MESH:D001172), arthritis (MESH:D001168), Chronic metabolic disorders (MESH:D002908), cognitive impairment (MESH:D003072), heart disease (MESH:D006331), hepatic diseases (MESH:D056486), inflammatory bowel disease (MESH:D015212), diabetes type 2 (MESH:D003924), bacterial infections (MESH:D001424)
- **Chemicals:** flavonols (MESH:D044948), rutin (MESH:D012431), 2,2-diphenyl-1-picrylhydrazyl (MESH:C004931), Agar (MESH:D000362), ciprofloxacin (MESH:D002939), benzoic acid (MESH:D019817), oxygen (MESH:D010100), gallic acid (MESH:D005707), phosphate (MESH:D010710), methanol (MESH:D000432), 3,5-dinitrosalicylic acid (MESH:C027011), NaCl (MESH:D012965), withanolide (MESH:D054358), Dimefox (MESH:C012920), blood glucose (MESH:D001786), Cyclohexane (MESH:C506365), cholesterol (MESH:D002784), Erythromycin (MESH:D004917), gentamicin (MESH:D005839), alkaloids (MESH:D000470), Ascorbic acid (MESH:D001205), Propylamine (MESH:D011437), alkane (MESH:D000473), 2 -methoxy-4-vinylphenol (MESH:C526552), Cyclopropane carboxamide (MESH:C538819), Terpenoids (MESH:D013729), phenolic acids (MESH:C017616), water (MESH:D014867), Caryophyllene oxide (MESH:C515179), hydrocarbon (MESH:D006838), fatty acids (MESH:D005227), Carbohydrate (MESH:D002241), Starch (MESH:D013213), phenols (MESH:D010636), amines (MESH:D000588), tannins (MESH:D013634), maleic anhydride (MESH:D008299), amino acid (MESH:D000596), 4-Hydroxy-3-methylacetophenone (MESH:C504550), Na+ (MESH:D012964), sodium phosphate (MESH:C018279), beta-caryophyllene (MESH:C024714), Helium (MESH:D006371), ASN88 (-), Acarbose (MESH:D020909), neral (MESH:C007076), glucose (MESH:D005947), flavonoid (MESH:D005419), hydrogen (MESH:D006859), epoxide (MESH:D004852), I2 (MESH:D007455), hexadecanoic acid (MESH:D019308), lipopolysaccharide (MESH:D008070), KI (MESH:C066186), lipid (MESH:D008055), DNSA (MESH:C001026), imipenem (MESH:D015378)
- **Species:** Salmonella enterica subsp. enterica serovar Typhi (no rank) [taxon 90370], Mus musculus (house mouse, species) [taxon 10090], Escherichia coli (E. coli, species) [taxon 562], Homo sapiens (human, species) [taxon 9606], Withania coagulans (Indian rennet, species) [taxon 180581], Matthiola incana (common stock, species) [taxon 3724]
- **Mutations:** 09 W, G09W
- **Cell lines:** ATCC — Homo sapiens (Human), Lung adenocarcinoma, Cancer cell line (CVCL_0023)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12923132/full.md

## Figures

12 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12923132/full.md

## References

98 references — full list in the complete paper: https://tomesphere.com/paper/PMC12923132/full.md

---
Source: https://tomesphere.com/paper/PMC12923132